Long-term risk of chronic liver disease in patients with celiac disease: a nationwide population-based, sibling-controlled cohort study
European Crohn's and Colitis Organisation, the Swedish Society for Medical Research (project#: PG-23-0315-H-02), FORTE (project#: 2016-00424), Takeda, and the Swiss National Science Foundation (project#: P500PM_210866).
Authors
- Peter H.R. Green (ORCID: https://orcid.org/0000-0001-6839-9634)
- Daniel A. Leffler (ORCID: https://orcid.org/0000-0002-0750-3386)
- Jiangwei Sun (ORCID: https://orcid.org/0000-0003-2252-684X)
- David Bergman (ORCID: https://orcid.org/0000-0003-4808-1762)
- Hannes Hagström (ORCID: https://orcid.org/0000-0002-8474-1759)
- Fahim Ebrahimi (ORCID: https://orcid.org/0000-0001-5862-966X)
- Benjamin Lebwohl (ORCID: https://orcid.org/0000-0001-9422-4774)
- Jonas Filip Ludvigsson (ORCID: https://orcid.org/0000-0003-1024-5602)
- Jialu Yao (ORCID: https://orcid.org/0009-0004-2238-6810)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Karolinska University Hospital (SE)
- Harvard University (US)
- Columbia University Irving Medical Center (US)
- University Hospital of Basel (CH)
- Karolinska Institutet (SE)
- Örebro University Hospital (SE)
- Takeda (United States) (US)
- Columbia University (US)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1016/j.lanepe.2024.101201
- Citations
- 5
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 9.06
Funders
- National Science Foundation
- European Crohn's and Colitis Organisation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Svenska Sällskapet för Medicinsk Forskning
- Vetenskapsrådet
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd